Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
The Journal of Practical Medicine ; (24): 1524-1528, 2018.
Artigo em Chinês | WPRIM | ID: wpr-697814

RESUMO

Objective To study the rationality about the application of clinical medication for diabetic microcirculation disorderturbance in a general hospital of level Ⅱ in Changshu. Methods Three hundred and fifty-nine patients with T2DM who received the clinical pathway treatment were enrolled in this study in a general hospital of level II in Changshu from July to December 2016. The statistical analysis was performed on the clinical application of microcirculation-improving drugs. The selection of microcirculation-improving drugs ,the drug utilization index(DUI),the intensity of microcirculation-improving drugs and the rate of drug combination were used as the evaluation criteria. Results The utilization rate of microcirculation-improving drugs was 94.43 %,and the combination rate was 73.75 %.The selection of microcirculation-improving drugs was the traditional Chinese medicine injections which activated blood circulation and vasodilators,with the DUI ranged from 0.9 to 1.1,and the intensity of microcirculation-improving drugs was 177.82 DDD. Conclusion The application of the clinical medication for the diabetic microcirculation disturbance was not standard,as a result,the indications of medication were not clear,and the indications of drug combination were not controlled strictly,the therapeutic regimen was unreasonable,and further management should be strengthened.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA